1Malogolowkin MH,Katzenstein H,Krailo MD,et al.Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma[J].J Clin Oncol,2006,24(18):2879-2884.
2Malogolowkin MH,Katzenstein H,Krailo MD,et al.Redefining the role of doxombicin for the treatment of children with hepatoblastoma[J].J Clin Oncol,2008,26(14):2379-2383.
3Suita S,Tajiri T,Takamatsu H,et al.Improve survival outome for hepatoblastoma based on an optimal chemotherapeutic regimen a report from the study group for pediatric solid malignant tumors in the Kyushu area[J].J Pediatr Surg,2004,39(2):195-198.
4Roebuck DJ,Perilongo G.Hepatoblastoma an oncological review[J].Pediatr Radiol,2006,36(3):183-186.
5Bulterys M,Goodman MT,Smith MA,et al.Cancer incidence and survival among Children and Adolescents:United States SEER Program 1975-1995.National Cancer Institute SEER Program[J].NIH Publication,1999,91:4649.
6Brown J,Perilongo G,Shaft E,et al.Pretreatment prognostic factors for children with hepatoblastoma results from the International Society of Pediatric Oncology(SIOP)Study SIOPEL[J].Eur J Cancer,2000,36:1418.
7Schnater JM,Kohler SE,Lamers WH,et al.Where dowe stand with hepatoblastoma?A review[J].Cancer,2003,98(4):668-678.
